- Home
- CATX vs PAHC Comparison
CATX vs PAHC Comparison
Compare CATX & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- PAHC
- Stock Information
- Founded
- CATX 1983
- PAHC 1946
- Country
- CATX United States
- PAHC United States
- Employees
- CATX N/A
- PAHC N/A
- Industry
- CATX Medical/Dental Instruments
- PAHC Biotechnology: Pharmaceutical Preparations
- Sector
- CATX Health Care
- PAHC Health Care
- Exchange
- CATX Nasdaq
- PAHC Nasdaq
- Market Cap
- CATX 782.7M
- PAHC 682.5M
- IPO Year
- CATX N/A
- PAHC 2014
- Fundamental
- Price
- CATX $7.88
- PAHC $24.46
- Analyst Decision
- CATX Strong Buy
- PAHC Sell
- Analyst Count
- CATX 9
- PAHC 3
- Target Price
- CATX $21.63
- PAHC $19.00
- AVG Volume (30 Days)
- CATX 737.4K
- PAHC 174.8K
- Earning Date
- CATX 11-12-2024
- PAHC 11-06-2024
- Dividend Yield
- CATX N/A
- PAHC 1.96%
- EPS Growth
- CATX N/A
- PAHC N/A
- EPS
- CATX N/A
- PAHC 0.43
- Revenue
- CATX $1,557,000.00
- PAHC $1,046,762,000.00
- Revenue This Year
- CATX N/A
- PAHC $21.75
- Revenue Next Year
- CATX N/A
- PAHC $12.67
- P/E Ratio
- CATX N/A
- PAHC $56.92
- Revenue Growth
- CATX N/A
- PAHC 7.17
- 52 Week Low
- CATX $2.30
- PAHC $9.49
- 52 Week High
- CATX $19.10
- PAHC $25.98
- Technical
- Relative Strength Index (RSI)
- CATX 19.19
- PAHC 56.80
- Support Level
- CATX $11.40
- PAHC $24.23
- Resistance Level
- CATX $12.82
- PAHC $25.98
- Average True Range (ATR)
- CATX 0.73
- PAHC 0.90
- MACD
- CATX -0.35
- PAHC 0.08
- Stochastic Oscillator
- CATX 0.10
- PAHC 60.21
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.
About PAHC Phibro Animal Health Corporation
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.